NexGel, Inc Common Stock (NXGL) Stock Price
NXGLStock
$0.35−85.63%52W
Market Cap$3.43M
P/E—
PEG Ratio—
Div yield—
Beta0.74
NXGL Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-82.10%
Price vs S&P 500 (4W)-18.37%
VGM Score52.00
NXGL Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | -$0.12 | -$0.52 | -329.83%(-$0.40) | |
| Q1 2026 | -$0.07 | -$0.11 | -57.14%(-$0.04) | |
| Q4 2025 | -$0.09 | -$0.15 | -65.33%(-$0.06) | |
| Q3 2025 | — | -$0.08 | — | |
| Q2 2025 | -$0.07 | -$0.10 | -41.14%(-$0.03) |
NXGL Analyst Recommendations
May 2026
Jun 2026
Jul 2026
Aug 2026
4.14
4.14
4.14
4.14
Industry Peers — Surgical & Medical Instruments(140)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
NXGLNexGel, Inc Common Stock | A | C | F | $0.35 |
| SYKStryker Corporation | C | B | C | $330.69 |
| MMM3M Company | C | D | C | $174.34 |
| BSXBoston Scientific Corp. | C | B | D | $46.84 |
| BDXBecton, Dickinson and Co. | B | D | B | $189.52 |
| MDLNMedline Inc. Class A common stock | C | D | C | $35.28 |
| RMDResMed Inc. | C | B | B | $240.33 |
| DXCMDexCom, Inc. | D | B | B | $90.82 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $337.47 |
| SOLVSolventum Corporation | C | C | B | $91.12 |
| BAXBaxter International Inc. | B | D | B | $26.13 |
About NexGel, Inc Common Stock
NexGel Inc manufactures aqueous polymer hydrogels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics applications. The company differentiates through proprietary manufacturing technologies, including electron beam cross-linking, that enable specialized custom gel development.